chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Eye disorder, Feeling abnormal, Full blood count, Gait disturbance
Clinical narrative: Felt sick for three days after vaccine and then starting 7 days after vaccine, symptoms began. Speech was affected and words were jumbled and not coming out right. Severe body tremors started affecting walking and doing daily tasks  Severe body and joint inflammation started. Extreme tinnitus and severe headaches with eye issues.  Memory was affected with lapses of time when I could not remember what I was doing or trying to do.  I was very spacey and my brain was in a fog.  Ocular migraines and vision issues started happening.  By June 15th I went to my doctor and admitted to Urgent Care ER for CBC blood work and CT scan.  Results were non conclusive.  Suggested that I get an MRI done. I did on June 20th. Also chest pain + shortness of breath
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inflammation, Loss of personal independence in daily activities, Magnetic resonance imaging, Malaise
Clinical narrative: Felt sick for three days after vaccine and then starting 7 days after vaccine, symptoms began. Speech was affected and words were jumbled and not coming out right. Severe body tremors started affecting walking and doing daily tasks  Severe body and joint inflammation started. Extreme tinnitus and severe headaches with eye issues.  Memory was affected with lapses of time when I could not remember what I was doing or trying to do.  I was very spacey and my brain was in a fog.  Ocular migraines and vision issues started happening.  By June 15th I went to my doctor and admitted to Urgent Care ER for CBC blood work and CT scan.  Results were non conclusive.  Suggested that I get an MRI done. I did on June 20th. Also chest pain + shortness of breath
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Migraine, Ophthalmological examination, Speech disorder, Tinnitus
Clinical narrative: Felt sick for three days after vaccine and then starting 7 days after vaccine, symptoms began. Speech was affected and words were jumbled and not coming out right. Severe body tremors started affecting walking and doing daily tasks  Severe body and joint inflammation started. Extreme tinnitus and severe headaches with eye issues.  Memory was affected with lapses of time when I could not remember what I was doing or trying to do.  I was very spacey and my brain was in a fog.  Ocular migraines and vision issues started happening.  By June 15th I went to my doctor and admitted to Urgent Care ER for CBC blood work and CT scan.  Results were non conclusive.  Suggested that I get an MRI done. I did on June 20th. Also chest pain + shortness of breath
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Visual impairment
Clinical narrative: Felt sick for three days after vaccine and then starting 7 days after vaccine, symptoms began. Speech was affected and words were jumbled and not coming out right. Severe body tremors started affecting walking and doing daily tasks  Severe body and joint inflammation started. Extreme tinnitus and severe headaches with eye issues.  Memory was affected with lapses of time when I could not remember what I was doing or trying to do.  I was very spacey and my brain was in a fog.  Ocular migraines and vision issues started happening.  By June 15th I went to my doctor and admitted to Urgent Care ER for CBC blood work and CT scan.  Results were non conclusive.  Suggested that I get an MRI done. I did on June 20th. Also chest pain + shortness of breath
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Product preparation error
Clinical narrative: Patient may have been given the diluent only.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness unilateral, Ear infection, Ear, nose and throat examination abnormal
Clinical narrative: I wore hearing aids before this incident. Three weeks after my second vaccine I got an ear infection. I am 55 years old and have never had an ear infection in my life. I was given antibiotic but then I lost most of my hearing in my left ear. The ENT said the hearing loss was not caused by a bacterial infection. They started me on a series of steroid injections in my inner ear. I can't take steroids orally due to internal bleeding issues. After the steroid shots, my word recognition improved by 20% in my left ear.
Age: 20.0
Sex: M
Vaccine: HEP
Symptoms: Underdose
Clinical narrative: No adverse event except pediatric dose given instead of adult dose
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Anti-GAD antibody positive, Blood calcium, Laboratory test, Latent autoimmune diabetes in adults
Clinical narrative: Pt developed auto-immune Diabetes of Adulthood (LADA) GAD-65 Ab +
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Hypotension, Pallor, Syncope
Clinical narrative: Vasovagal syncope followed by long lasting tinnitus in the right ear. Tinnitus is still present (7 months later).
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness unilateral, Incomplete course of vaccination, Syncope, Tinnitus
Clinical narrative: Vasovagal syncope followed by long lasting tinnitus in the right ear. Tinnitus is still present (7 months later).
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Chills, Decreased appetite, Fatigue, Lymphadenopathy
Clinical narrative: redness in her arm/entire shoulder turned red; she has swelling on the left arm and hurting; Itching; enlarged lymph node under arm is hurting/is very sore; enlarged lymph node under arm is hurting/is very sore; soreness in her arm/she received the vaccine and has been sore ever since/swelling on the left arm and hurting; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266) via an unspecified route of administration left arm (Left shoulder) on 20Feb2021 (at the age of 72-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Jun2020 She had severe Covid last Jun and almost died, leukaemia, lymph node was enlarged before. There were no concomitant medications. Patient was reported that she was afraid the soreness in her arm wasn't going to go away because it is still pretty much the same soreness, but her entire shoulder turned red today. Which she knows they say you can get redness in the first day or two, but she is on day 6 now. On 21Feb2021 The patient also had an enlarged lymph node under that arm which is being watched with her leukemia and the lymph node is enlarged more and was very sore. The soreness in her arm started the very night of the Saturday (20Feb2021) when she received the vaccine and has been sore ever since. The redness/ redness in her arm started on 25Feb2021. The patient states that her arm is itching and is irritating and very uncomfortable which started 24Feb2021 or the day before and it comes and goes. She explains she is a leukemia patient and her lymph node was enlarged before, but its never been hurting her. It's been hurting her ever since the second day of the vaccine. On 25Feb2021 also reported she had swelling on the left arm and hurting. Prior Vaccinations (within 4 weeks): none. Patient did not have any AE(s) require a visit to Emergency room, Physician's office. The outcome of event for Lymph node pain, pain in arm, redness in her arm was not recovered and rest all event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: redness in her arm/entire shoulder turned red; she has swelling on the left arm and hurting; Itching; enlarged lymph node under arm is hurting/is very sore; enlarged lymph node under arm is hurting/is very sore; soreness in her arm/she received the vaccine and has been sore ever since/swelling on the left arm and hurting; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266) via an unspecified route of administration left arm (Left shoulder) on 20Feb2021 (at the age of 72-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Jun2020 She had severe Covid last Jun and almost died, leukaemia, lymph node was enlarged before. There were no concomitant medications. Patient was reported that she was afraid the soreness in her arm wasn't going to go away because it is still pretty much the same soreness, but her entire shoulder turned red today. Which she knows they say you can get redness in the first day or two, but she is on day 6 now. On 21Feb2021 The patient also had an enlarged lymph node under that arm which is being watched with her leukemia and the lymph node is enlarged more and was very sore. The soreness in her arm started the very night of the Saturday (20Feb2021) when she received the vaccine and has been sore ever since. The redness/ redness in her arm started on 25Feb2021. The patient states that her arm is itching and is irritating and very uncomfortable which started 24Feb2021 or the day before and it comes and goes. She explains she is a leukemia patient and her lymph node was enlarged before, but its never been hurting her. It's been hurting her ever since the second day of the vaccine. On 25Feb2021 also reported she had swelling on the left arm and hurting. Prior Vaccinations (within 4 weeks): none. Patient did not have any AE(s) require a visit to Emergency room, Physician's office. The outcome of event for Lymph node pain, pain in arm, redness in her arm was not recovered and rest all event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Lymph node pain, Lymphadenopathy, Pruritus, Vaccination site pain
Clinical narrative: redness in her arm/entire shoulder turned red; she has swelling on the left arm and hurting; Itching; enlarged lymph node under arm is hurting/is very sore; enlarged lymph node under arm is hurting/is very sore; soreness in her arm/she received the vaccine and has been sore ever since/swelling on the left arm and hurting; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266) via an unspecified route of administration left arm (Left shoulder) on 20Feb2021 (at the age of 72-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Jun2020 She had severe Covid last Jun and almost died, leukaemia, lymph node was enlarged before. There were no concomitant medications. Patient was reported that she was afraid the soreness in her arm wasn't going to go away because it is still pretty much the same soreness, but her entire shoulder turned red today. Which she knows they say you can get redness in the first day or two, but she is on day 6 now. On 21Feb2021 The patient also had an enlarged lymph node under that arm which is being watched with her leukemia and the lymph node is enlarged more and was very sore. The soreness in her arm started the very night of the Saturday (20Feb2021) when she received the vaccine and has been sore ever since. The redness/ redness in her arm started on 25Feb2021. The patient states that her arm is itching and is irritating and very uncomfortable which started 24Feb2021 or the day before and it comes and goes. She explains she is a leukemia patient and her lymph node was enlarged before, but its never been hurting her. It's been hurting her ever since the second day of the vaccine. On 25Feb2021 also reported she had swelling on the left arm and hurting. Prior Vaccinations (within 4 weeks): none. Patient did not have any AE(s) require a visit to Emergency room, Physician's office. The outcome of event for Lymph node pain, pain in arm, redness in her arm was not recovered and rest all event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling
Clinical narrative: redness in her arm/entire shoulder turned red; she has swelling on the left arm and hurting; Itching; enlarged lymph node under arm is hurting/is very sore; enlarged lymph node under arm is hurting/is very sore; soreness in her arm/she received the vaccine and has been sore ever since/swelling on the left arm and hurting; This is a spontaneous report from a contactable consumer (patient). A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266) via an unspecified route of administration left arm (Left shoulder) on 20Feb2021 (at the age of 72-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included Jun2020 She had severe Covid last Jun and almost died, leukaemia, lymph node was enlarged before. There were no concomitant medications. Patient was reported that she was afraid the soreness in her arm wasn't going to go away because it is still pretty much the same soreness, but her entire shoulder turned red today. Which she knows they say you can get redness in the first day or two, but she is on day 6 now. On 21Feb2021 The patient also had an enlarged lymph node under that arm which is being watched with her leukemia and the lymph node is enlarged more and was very sore. The soreness in her arm started the very night of the Saturday (20Feb2021) when she received the vaccine and has been sore ever since. The redness/ redness in her arm started on 25Feb2021. The patient states that her arm is itching and is irritating and very uncomfortable which started 24Feb2021 or the day before and it comes and goes. She explains she is a leukemia patient and her lymph node was enlarged before, but its never been hurting her. It's been hurting her ever since the second day of the vaccine. On 25Feb2021 also reported she had swelling on the left arm and hurting. Prior Vaccinations (within 4 weeks): none. Patient did not have any AE(s) require a visit to Emergency room, Physician's office. The outcome of event for Lymph node pain, pain in arm, redness in her arm was not recovered and rest all event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Blood creatinine normal, Body temperature fluctuation
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Ear pain, Fatigue, Haematocrit normal, Influenza virus test negative
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Joint stiffness, Mononucleosis heterophile test negative, Musculoskeletal chest pain, Musculoskeletal pain
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Pain, Red blood cell count decreased, SARS-CoV-2 antibody test negative, SARS-CoV-2 test negative
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis normal
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Body temperature fluctuation, Confusional state, Fatigue
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Malaise, Musculoskeletal pain, Pain, SARS-CoV-2 antibody test
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: fluctuating temp; Musculoskeletal pain to Left side of body: Mainly left upper body; The injected site was sore, mild; Malaise; Extreme fatigue; brain fog; intermittent confusion; severe pain to Lt shoulder and clavicle; severe pain to Lt shoulder and clavicle; This is a spontaneous report from a contactable nurse (patient herself). A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via intramuscular route, administered in left arm on 03Feb2021 11:45 (age at vaccination: 50 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included rheumatic fever, erythema nodosum, osteonecrosis, cataract and depression. Concomitant medication(s) included bupropion; apap; colecalciferol (VITAMIN D); ibuprofen (MOTRIN). The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via intramuscular route, administered in left arm on 13Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunisation and experienced musculoskeletal pain. The patient did not receive any other vaccine in four weeks. The patient was allergic to ciprofloxacin and Bactrim. On 04Feb2021 02:00, 12 hours after the vaccination, the patient experienced fluctuating temp, musculoskeletal pain to left side of body: mainly left upper body, the injected site was sore, mild, malaise, extreme fatigue, brain fog, intermittent confusion, 17 hours later woke up with severe pain to shoulder and clavicle. The musculoskeletal pain was continuing and the pain was at various sites, forms and levels. Severe-moderate/shooting and needle pain, moderate/radiating pain, moderate-mild/dull pain, mild/annoying persistent uncomfortable pain. The adverse event resulted in physician's office visit. The patient did not receive any treatment for the adverse event. The patient was not diagnosed with covid-19 prior to vaccination nor was tested since vaccination. On 23Feb2021, the patient underwent lab tests and procedures which included sars-cov-2 antibody test which was negative and body temperature was fluctuating. The outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Feeling abnormal, Headache, Nausea, Photophobia
Clinical narrative: Debilitating headache; Mental fog; Mild nausea; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old male patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: EN5318) dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 12:15 as dose 2, single (at the age of 65-year-old) for covid-19 immunization. Medical history included hypertension, arthritis and migraine without aura from an unknown date and unknown if ongoing. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.)), carvedilol (COREG), hydrochlorothiazide (HCT) irbesartan (IRBESARTAN) and statin taken for hypertension, start and stop date were not reported. The patient previously took demerol and experienced drug hypersensitivity Historical vaccine included received first dose of BNT162B2 (COMIRNATY,Formulation: Solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 25Jan2021 14:15 (at the age of 65-years-old) as single for COVID-19 immunization. On 16Feb2021 14:00 The patient experienced debilitating headache starting an hour or so after the injection, mental fog and mild nausea. Headache did not respond to OTC pain medication. Now, three days later still requires 10 mg of Oxycontin every four hours to control, waking her up in the middle of the night with pain. Three days later it had not subsided. she finally realized it was a migraine headache, she got migraines from food triggers, (caffeine, sulfates and peppers) but she has not had one come to fruition in thirty years, she got visual triggers and take Rizatriptan as a prophylactic, it (and older drugs used in the past) has never failed to prevent one. she did not get a visual disruption before pain started. No other vaccine in four weeks was given. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. Therapeutic measures were taken as a result of debilitating headache, mental fog, mild nausea. The outcome of the events was not recovered.  .  Follow-up (28May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: Debilitating headache; Mental fog; Mild nausea; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old male patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: EN5318) dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 12:15 as dose 2, single (at the age of 65-year-old) for covid-19 immunization. Medical history included hypertension, arthritis and migraine without aura from an unknown date and unknown if ongoing. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.)), carvedilol (COREG), hydrochlorothiazide (HCT) irbesartan (IRBESARTAN) and statin taken for hypertension, start and stop date were not reported. The patient previously took demerol and experienced drug hypersensitivity Historical vaccine included received first dose of BNT162B2 (COMIRNATY,Formulation: Solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 25Jan2021 14:15 (at the age of 65-years-old) as single for COVID-19 immunization. On 16Feb2021 14:00 The patient experienced debilitating headache starting an hour or so after the injection, mental fog and mild nausea. Headache did not respond to OTC pain medication. Now, three days later still requires 10 mg of Oxycontin every four hours to control, waking her up in the middle of the night with pain. Three days later it had not subsided. she finally realized it was a migraine headache, she got migraines from food triggers, (caffeine, sulfates and peppers) but she has not had one come to fruition in thirty years, she got visual triggers and take Rizatriptan as a prophylactic, it (and older drugs used in the past) has never failed to prevent one. she did not get a visual disruption before pain started. No other vaccine in four weeks was given. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. Therapeutic measures were taken as a result of debilitating headache, mental fog, mild nausea. The outcome of the events was not recovered.  .  Follow-up (28May2021): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Nausea
Clinical narrative: Debilitating headache; Mental fog; Mild nausea; This is a spontaneous report from a contactable consumer (Patient). A 65-year-old male patient received bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot Number: EN5318) dose 2 via an unspecified route of administration, administered in Arm Left on 16Feb2021 12:15 as dose 2, single (at the age of 65-year-old) for covid-19 immunization. Medical history included hypertension, arthritis and migraine without aura from an unknown date and unknown if ongoing. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.)), carvedilol (COREG), hydrochlorothiazide (HCT) irbesartan (IRBESARTAN) and statin taken for hypertension, start and stop date were not reported. The patient previously took demerol and experienced drug hypersensitivity Historical vaccine included received first dose of BNT162B2 (COMIRNATY,Formulation: Solution for injection, Batch/Lot Number: EL9261), via an unspecified route of administration, administered in Arm Left on 25Jan2021 14:15 (at the age of 65-years-old) as single for COVID-19 immunization. On 16Feb2021 14:00 The patient experienced debilitating headache starting an hour or so after the injection, mental fog and mild nausea. Headache did not respond to OTC pain medication. Now, three days later still requires 10 mg of Oxycontin every four hours to control, waking her up in the middle of the night with pain. Three days later it had not subsided. she finally realized it was a migraine headache, she got migraines from food triggers, (caffeine, sulfates and peppers) but she has not had one come to fruition in thirty years, she got visual triggers and take Rizatriptan as a prophylactic, it (and older drugs used in the past) has never failed to prevent one. she did not get a visual disruption before pain started. No other vaccine in four weeks was given. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. Therapeutic measures were taken as a result of debilitating headache, mental fog, mild nausea. The outcome of the events was not recovered.  .  Follow-up (28May2021): Follow-up attempts completed. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Flushing, Nausea
Clinical narrative: Approximately 5 minutes after vaccine administered pt became flushed; Nauseated; Lightheadedness; This is a spontaneous report from a contactable pharmacist. A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6198), dose 2 intramuscular on 19Feb2021 13:45 (at the age of 42-year-old) as dose 2, single for COVID-19 immunization. Medical history included ongoing migraine. Concomitant medication(s) included fish oil (capsule); acetylsalicylic acid, butalbital, caffeine, phenacetin (FIORINAL [ACETYLSALICYLIC ACID; BUTALBITAL; CAFFEINE; PHENACETIN]) and multivitamin taken for an unspecified indication, start and stop date were not reported (other medications the patient received within 2 weeks of vaccination). Pregnancy was unknown at that time of vaccination. The patient previously received first dose of BNT162B2 (Lot number: EL3246), intramuscular administered on 29Jan2021 for COVID-19 immunization and experienced lightheaded, felt dizzy, nausea, ceftriaxone for allergy, nausea, diaphoresis, Imitrex for allergy and nitrofurantoin for allergy, rash, nausea, vomiting, headache. Prior to vaccination, the patient diagnosed with COVID-19 was unknown. Since the vaccination, the patient had been tested for COVID-19 was unknown. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered at Public Health Clinic. On 19Feb2021 13:50, approximately 5 minutes after vaccine administered patient became flushed, nauseated and lightheadedness. Patient alerted observer and medical assistant called for transfer of the patient to the first aid office. Patient then evaluated by EMS on duty. At 14:35, Patient symptoms resolved, and patient was cleared by EMS to discharge home. Ambulated on own without weakness. There was no treatment for the events. The patient underwent lab tests and procedures which included BP: 136/66 on 29Jan2021, 142/80 on 19Feb2021, HR: 89 on 29Jan2021, SaO2: 95 % on 29Jan2021, 100 % on 19Feb2021. The clinical outcome of events was recovered on 19Feb2021 14:35.  Follow up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Dizziness, Flushing, Heart rate, Nausea
Clinical narrative: Approximately 5 minutes after vaccine administered pt became flushed; Nauseated; Lightheadedness; This is a spontaneous report from a contactable pharmacist. A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6198), dose 2 intramuscular on 19Feb2021 13:45 (at the age of 42-year-old) as dose 2, single for COVID-19 immunization. Medical history included ongoing migraine. Concomitant medication(s) included fish oil (capsule); acetylsalicylic acid, butalbital, caffeine, phenacetin (FIORINAL [ACETYLSALICYLIC ACID; BUTALBITAL; CAFFEINE; PHENACETIN]) and multivitamin taken for an unspecified indication, start and stop date were not reported (other medications the patient received within 2 weeks of vaccination). Pregnancy was unknown at that time of vaccination. The patient previously received first dose of BNT162B2 (Lot number: EL3246), intramuscular administered on 29Jan2021 for COVID-19 immunization and experienced lightheaded, felt dizzy, nausea, ceftriaxone for allergy, nausea, diaphoresis, Imitrex for allergy and nitrofurantoin for allergy, rash, nausea, vomiting, headache. Prior to vaccination, the patient diagnosed with COVID-19 was unknown. Since the vaccination, the patient had been tested for COVID-19 was unknown. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered at Public Health Clinic. On 19Feb2021 13:50, approximately 5 minutes after vaccine administered patient became flushed, nauseated and lightheadedness. Patient alerted observer and medical assistant called for transfer of the patient to the first aid office. Patient then evaluated by EMS on duty. At 14:35, Patient symptoms resolved, and patient was cleared by EMS to discharge home. Ambulated on own without weakness. There was no treatment for the events. The patient underwent lab tests and procedures which included BP: 136/66 on 29Jan2021, 142/80 on 19Feb2021, HR: 89 on 29Jan2021, SaO2: 95 % on 29Jan2021, 100 % on 19Feb2021. The clinical outcome of events was recovered on 19Feb2021 14:35.  Follow up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation
Clinical narrative: Approximately 5 minutes after vaccine administered pt became flushed; Nauseated; Lightheadedness; This is a spontaneous report from a contactable pharmacist. A 42-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EN6198), dose 2 intramuscular on 19Feb2021 13:45 (at the age of 42-year-old) as dose 2, single for COVID-19 immunization. Medical history included ongoing migraine. Concomitant medication(s) included fish oil (capsule); acetylsalicylic acid, butalbital, caffeine, phenacetin (FIORINAL [ACETYLSALICYLIC ACID; BUTALBITAL; CAFFEINE; PHENACETIN]) and multivitamin taken for an unspecified indication, start and stop date were not reported (other medications the patient received within 2 weeks of vaccination). Pregnancy was unknown at that time of vaccination. The patient previously received first dose of BNT162B2 (Lot number: EL3246), intramuscular administered on 29Jan2021 for COVID-19 immunization and experienced lightheaded, felt dizzy, nausea, ceftriaxone for allergy, nausea, diaphoresis, Imitrex for allergy and nitrofurantoin for allergy, rash, nausea, vomiting, headache. Prior to vaccination, the patient diagnosed with COVID-19 was unknown. Since the vaccination, the patient had been tested for COVID-19 was unknown. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered at Public Health Clinic. On 19Feb2021 13:50, approximately 5 minutes after vaccine administered patient became flushed, nauseated and lightheadedness. Patient alerted observer and medical assistant called for transfer of the patient to the first aid office. Patient then evaluated by EMS on duty. At 14:35, Patient symptoms resolved, and patient was cleared by EMS to discharge home. Ambulated on own without weakness. There was no treatment for the events. The patient underwent lab tests and procedures which included BP: 136/66 on 29Jan2021, 142/80 on 19Feb2021, HR: 89 on 29Jan2021, SaO2: 95 % on 29Jan2021, 100 % on 19Feb2021. The clinical outcome of events was recovered on 19Feb2021 14:35.  Follow up attempts are completed. No further information is expected.